
New real-world data highlight sustained response and remission rates with esketamine nasal spray for patients with treatment-resistant depression.

New real-world data highlight sustained response and remission rates with esketamine nasal spray for patients with treatment-resistant depression.

Lauren Madigan, MD, shares open-label extension results demonstrating sustained improvements with avapritinib in patients with indolent systemic mastocytosis.

Melinda Gooderham, MD, MSc, FRCPC, discusses findings from the Latitude PsO 3001 and Latitude PsO 3002 studies evaluating zasocitinib.

Todd Schlesinger, MD, discusses how new immunotherapies and multidisciplinary care are reshaping treatment approaches for patients with advanced skin cancers.

Martina Porter, MD, discusses long-term results from the phase 3 STOP-HS program evaluating povorcitinib in patients with hidradenitis suppurativa.

April Armstrong, MD, MPH, discusses findings from the TRACE study, which evaluated the real-world effectiveness of tralokinumab in patients with skin of color with AD.

Linda Stein Gold, MD, shares efficacy and safety findings from the ICONIC-ADVANCE studies in moderate to severe psoriasis.

Clinicians need to adjust their diagnostic lens and counseling strategies in patients with skin of color, explained Joseph Lam, MD.

James Song, MD, discusses the direction teledermatology is heading and how more inclusive clinical trials can improve outcomes for patients of color.

Linda Stein Gold, MD, shares recent findings from the pooled phase 3 analysis of the ADORING 1 and ADORING 2 trials for atopic dermatitis.

John Barkett, MBA, discusses how health care price transparency can affect both patient out-of-pocket costs and overall health care spending.

Christopher Shade, PhD, shares insights for managed care leaders on oral peptide therapies.

Findings show sustained reductions in HbA1c, weight, blood pressure, inflammation, and lipids in patients with T2D and ASCVD or CKD.

Making health care prices public was supposed to cut costs. The reality is more complicated.

Active or severe atopic dermatitis throughout childhood and adolescence does not increase cardiometabolic risk, according to new research.

Conduction system pacing was found to be inferior to biventricular pacing for key outcomes in HFrEF with left bundle-branch block, despite lower costs.

Pediatric health coaching offers a workforce-driven solution to provide support that traditional care models often lack, with the potential to improve outcomes and reduce long-term costs.

James Song, MD, previews new oral therapies and guidelines psoriasis, atopic dermatitis, and chronic spontaneous urticaria.

New research shows that cardiovascular protection from GLP-1 receptor agonists such as semaglutide and tirzepatide diminishes within months of discontinuation.

Factual tone, credible sources, and clinician representation increase trust and engagement, while humor may undermine vaccine messaging effectiveness.

Study supports broader use of transient elastography to detect advanced liver fibrosis in patients with metabolic dysfunction–associated steatotic liver disease.


Long-term adherence to healthy behaviors reduces the risk of cardiovascular disease and type 2 diabetes, even among individuals taking antihypertensive medications.

Vutrisiran kept a favorable safety profile in patients with transthyretin amyloidosis treated for up to 58 months, with AE rates comparable to placebo and no new safety concerns.

AI could reduce administrative burden, improve diagnosis, and streamline prior authorization—but it could also fuel care cascades, upcoding, and unsustainable spending.

Sivelestat significantly reduced the incidence of postoperative ARDS, lowered 90-day mortality, and suppressed inflammatory biomarkers linked to lung injury.

Left bundle-branch pacing significantly lowered the combined risk of death or heart failure hospitalization compared with conventional biventricular pacing.

Intensive lifestyle programs for childhood obesity can prevent long-term chronic disease.

A Cleveland Clinic study shows a medically trained AI system can rapidly screen electronic health records to identify eligible participants for rare disease clinical trials.

A new study finds one-third of ambulatory patients with heart failure with reduced ejection fraction overestimate their life expectancy.